These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 11533610

  • 21. On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer.
    Smollich M, Götte M, Yip GW, Yong ES, Kersting C, Fischgräbe J, Radke I, Kiesel L, Wülfing P.
    Breast Cancer Res Treat; 2007 Dec; 106(3):361-9. PubMed ID: 17295044
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11.
    Trapani AJ, De Lombaert S, Kuzmich S, Jeng AY.
    J Cardiovasc Pharmacol; 1995 Dec; 26 Suppl 3():S69-71. PubMed ID: 8587471
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner.
    Kalk P, Sharkovska Y, Kashina E, von Websky K, Relle K, Pfab T, Alter M, Guillaume P, Provost D, Hoffmann K, Fischer Y, Hocher B.
    Hypertension; 2011 Apr; 57(4):755-63. PubMed ID: 21339476
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetic and pharmacodynamic properties of SOL1: a novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme.
    Nelissen J, Lemkens P, Sann H, Bindl M, Bassissi F, Jasserand D, De Mey JG, Janssen BJ.
    Life Sci; 2012 Oct 15; 91(13-14):587-92. PubMed ID: 22365954
    [Abstract] [Full Text] [Related]

  • 29. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme.
    Woods M, Mitchell JA, Wood EG, Barker S, Walcot NR, Rees GM, Warner TD.
    Mol Pharmacol; 1999 May 15; 55(5):902-9. PubMed ID: 10220569
    [Abstract] [Full Text] [Related]

  • 30. Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failure.
    Dickstein K, De Voogd HJ, Miric MP, Willenbrock R, Mitrovic V, Pacher R, Koopman PA.
    Am J Cardiol; 2004 Jul 15; 94(2):237-9. PubMed ID: 15246912
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme.
    De Lombaert S, Ghai RD, Jeng AY, Trapani AJ, Webb RL.
    Biochem Biophys Res Commun; 1994 Oct 14; 204(1):407-12. PubMed ID: 7945387
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Design and synthesis of a potent and selective endothelin-converting enzyme inhibitor, CGS 35066.
    Jeng AY, De Lombaert S, Beil ME, Bruseo CW, Savage P, Chou M, Trapani AJ.
    J Cardiovasc Pharmacol; 2000 Nov 14; 36(5 Suppl 1):S36-9. PubMed ID: 11078330
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Altered expression of enzymes regulating the activity of endothelin-1 in the lower segment of the human amnion during labor.
    Kotani T, Iwase A, Tsuda H, Mano Y, Yamamoto E, Nakano T, Hasegawa Y, Li H, Sumigama S, Itakura A, Kikkawa F.
    Biol Reprod; 2013 Sep 14; 89(3):52. PubMed ID: 23863409
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.